
Opinion|Videos|May 27, 2025
Ultra-Low PSA Threshold vs Traditional Thresholds In Clinical Practice
Author(s)Neal Shore, MD, FACS
Exploring the impact of ultra-sensitive PSA testing on treatment decisions for metastatic hormone-sensitive prostate cancer, enhancing patient outcomes and care efficiency.
Advertisement
Episodes in this series

Comparison of PSA Thresholds
Key Themes:
- Comparison between ultra-low threshold (<0.02 ng/mL) and traditional thresholds (<0.1 or <0.2 ng/mL)
- Sensitivity and specificity considerations
- Prognostic value of different PSA cutoff points
Expert Insights:
- Dr Shore discussed the differences between the ultra-low PSA threshold and more conventional thresholds commonly used in clinical practice.
The conversation addressed the sensitivity, specificity, and potential prognostic significance of various PSA cutoff points.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5












